THNR Overview

Profile

Name:

Amplify Weight Loss Drug & Treatment ETF

Assets under management:

$3 M

Expense ratio:

0.59%

Inception date:

-

Website:

-

Last ex-dividend date:

December 30, 2024

Next ex-dividend date:

N/A

Description:

THNR ETF is an exchange-traded fund that focuses on companies involved in renewable energy and sustainable practices. It aims to provide investors with exposure to the growing green economy while promoting environmental sustainability. The fund is designed for those looking to invest in eco-friendly businesses.

Top holdings

Name
Weight
LLY logo
Eli Lilly and Company(LLY)
17.37 %
NVO logo
Novo Nordisk A/S(NVO)
12.55 %
Roche Holding AG(ROG.SW)
6.34 %
AMGN logo
Amgen(AMGN)
6.17 %
AZN logo
AstraZeneca(AZN)
6.03 %
Chugai Pharmaceutical Co Ltd(4519.T)
5.54 %
PFE logo
Pfizer(PFE)
5.49 %
TMO logo
Thermo Fisher Scientific(TMO)
5.27 %
MRK logo
Merck & Co(MRK)
4.87 %
FUJIFILM Holdings Corp(4901.T)
4.07 %
Merck KGaA(MRK.DE)
3.55 %
Innovent Biologics Inc(1801.HK)
3.53 %
TEVA logo
Teva Pharmaceutical Industries Limited(TEVA)
3.25 %
MITSUBISHI CHEMICAL GROUP CORP(4188.T)
3.17 %
WST logo
West Pharmaceutical Services(WST)
3.10 %
Zealand Pharma A/S(ZEAL.CO)
2.25 %
GPCR logo
Structure Therapeutics(GPCR)
1.68 %
VKTX logo
Viking Therapeutics(VKTX)
1.43 %
HIMS logo
Hims & Hers Health(HIMS)
1.19 %
Gerresheimer AG(GXI.DE)
0.54 %
Hanmi Pharm Co Ltd(128940.KS)
0.48 %
Bachem Holding AG(BANB.SW)
0.38 %
United Laboratories International Holdings Ltd/The(3933.HK)
0.36 %
Invesco Government & Agency Portfolio 12/31/2031(AGPXX)
0.36 %
OPK logo
OPKO Health(OPK)
0.28 %
Ypsomed Holding AG(YPSN.SW)
0.26 %
ALT logo
Altimmune(ALT)
0.18 %
Cash & Other(Cash&Other)
0.14 %
TERN logo
Terns Pharmaceuticals(TERN)
0.10 %
Gubra A/S(GUBRA.CO)
0.07 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$22.20
THNR price is $22.20

Price All-time High

$28.69
THNR price is currently -22.62% below its historical high of $28.69

Price Most Recent Change

-0.98%
THNR price was down -0.98% on Mar 13, 2025

Price YTD Change

-1.55%
THNR price is down -1.55% since January 1st

Price 1-Year Change

-
THNR price 1-year change is unknown

Price 3-Year Change

-
THNR price 3-year change is unknown

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.57
THNR beta is 0.57

200-day SMA

$25.07
THNR price is currently -11.45% below its 200-day simple moving average

14-day RSI

35.82
THNR 14-day relative strength index is 35.82

30-day Relative Volume

5.24
THNR 30-day relative volume is 5.24

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Last Paid Dividend

$0.22
THNR last dividend was $0.22 per share, with an ex-dividend date of December 30, 2024

TTM Dividend Per Share

$0.22
THNR TTM dividend per share is $0.22

TTM Dividend Per Share 1-Year Change

-
THNR TTM dividend per share 1-year change is unknown

TTM Dividend Per Share 3-Year Change

-
THNR TTM dividend per share 3-year change is unknown

Dividend yield

TTM Dividend Yield

0.99%
THNR TTM dividend yield is 0.99%

TTM Dividend Yield 1-Year Change

-
THNR TTM dividend yield 1-year change is unknown

Top holdings

Name
Weight
LLY logo
Eli Lilly and Company(LLY)
17.37 %
NVO logo
Novo Nordisk A/S(NVO)
12.55 %
Roche Holding AG(ROG.SW)
6.34 %
AMGN logo
Amgen(AMGN)
6.17 %
AZN logo
AstraZeneca(AZN)
6.03 %
Chugai Pharmaceutical Co Ltd(4519.T)
5.54 %
PFE logo
Pfizer(PFE)
5.49 %
TMO logo
Thermo Fisher Scientific(TMO)
5.27 %
MRK logo
Merck & Co(MRK)
4.87 %
FUJIFILM Holdings Corp(4901.T)
4.07 %
Merck KGaA(MRK.DE)
3.55 %
Innovent Biologics Inc(1801.HK)
3.53 %
TEVA logo
Teva Pharmaceutical Industries Limited(TEVA)
3.25 %
MITSUBISHI CHEMICAL GROUP CORP(4188.T)
3.17 %
WST logo
West Pharmaceutical Services(WST)
3.10 %
Zealand Pharma A/S(ZEAL.CO)
2.25 %
GPCR logo
Structure Therapeutics(GPCR)
1.68 %
VKTX logo
Viking Therapeutics(VKTX)
1.43 %
HIMS logo
Hims & Hers Health(HIMS)
1.19 %
Gerresheimer AG(GXI.DE)
0.54 %
Hanmi Pharm Co Ltd(128940.KS)
0.48 %
Bachem Holding AG(BANB.SW)
0.38 %
United Laboratories International Holdings Ltd/The(3933.HK)
0.36 %
Invesco Government & Agency Portfolio 12/31/2031(AGPXX)
0.36 %
OPK logo
OPKO Health(OPK)
0.28 %
Ypsomed Holding AG(YPSN.SW)
0.26 %
ALT logo
Altimmune(ALT)
0.18 %
Cash & Other(Cash&Other)
0.14 %
TERN logo
Terns Pharmaceuticals(TERN)
0.10 %
Gubra A/S(GUBRA.CO)
0.07 %

Analyst ratings

FAQ

  • What is THNR?
  • Does THNR pay dividends?
  • What stocks are in THNR?
  • What is the current assets under management for THNR?
  • What is THNR average volume?
  • What is THNR expense ratio?
  • What is THNR inception date?

What is THNR?

THNR ETF is an exchange-traded fund that focuses on companies involved in renewable energy and sustainable practices. It aims to provide investors with exposure to the growing green economy while promoting environmental sustainability. The fund is designed for those looking to invest in eco-friendly businesses.

Does THNR pay dividends?

Yes, the Amplify Weight Loss Drug & Treatment ETF does pays dividends, with the most recent payment being $0.22 per share. The last ex-dividend date was on December 30, 2024, and the next ex-dividend date has not been announced yet

What stocks are in THNR?

As of today, Amplify Weight Loss Drug & Treatment ETF inlcudes 30 holdings, with 15 of them being companies from 8 different countries and 2 sectors. The most weighted holdings are Eli Lilly and Company (17.37%), Novo Nordisk A/S (12.55%) and Roche Holding AG (6.34%)

What is the current assets under management for THNR?

Assets under management of Amplify Weight Loss Drug & Treatment ETF is $3 M

What is THNR average volume?

Average volume of Amplify Weight Loss Drug & Treatment ETF is $7357

What is THNR expense ratio?

Expense ratio of Amplify Weight Loss Drug & Treatment ETF is 0.59%

What is THNR inception date?

null